HUE050953T2 - Acetilkolineszteráz inhibitor vegyületek és 5HT4 szerotonerg receptor agonisták promnesia hatással, eljárások elõállításukra és ezeket a vegyületeket tartalmazó gyógyászati kompozíciók - Google Patents
Acetilkolineszteráz inhibitor vegyületek és 5HT4 szerotonerg receptor agonisták promnesia hatással, eljárások elõállításukra és ezeket a vegyületeket tartalmazó gyógyászati kompozíciókInfo
- Publication number
- HUE050953T2 HUE050953T2 HUE14806879A HUE14806879A HUE050953T2 HU E050953 T2 HUE050953 T2 HU E050953T2 HU E14806879 A HUE14806879 A HU E14806879A HU E14806879 A HUE14806879 A HU E14806879A HU E050953 T2 HUE050953 T2 HU E050953T2
- Authority
- HU
- Hungary
- Prior art keywords
- promnesia
- preparation
- methods
- pharmaceutical compositions
- effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1355155A FR3006686A1 (fr) | 2013-06-05 | 2013-06-05 | Composes inhibiteurs de l'acetylcholinesterase et agonistes des recepteurs serotoninergiques 5ht4, a effet promnesiant, leurs procedes de preparation et compositions pharmaceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE050953T2 true HUE050953T2 (hu) | 2021-01-28 |
Family
ID=49546495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE14806879A HUE050953T2 (hu) | 2013-06-05 | 2014-05-19 | Acetilkolineszteráz inhibitor vegyületek és 5HT4 szerotonerg receptor agonisták promnesia hatással, eljárások elõállításukra és ezeket a vegyületeket tartalmazó gyógyászati kompozíciók |
Country Status (13)
Country | Link |
---|---|
US (1) | US9663465B2 (hu) |
EP (1) | EP3004058B1 (hu) |
JP (1) | JP6386541B2 (hu) |
CN (1) | CN105705488B (hu) |
DK (1) | DK3004058T3 (hu) |
ES (1) | ES2808669T3 (hu) |
FR (1) | FR3006686A1 (hu) |
HK (1) | HK1225381A1 (hu) |
HR (1) | HRP20201402T1 (hu) |
HU (1) | HUE050953T2 (hu) |
PL (1) | PL3004058T3 (hu) |
PT (1) | PT3004058T (hu) |
WO (1) | WO2014195593A2 (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3628660A1 (en) * | 2018-09-28 | 2020-04-01 | Université de Caen Normandie | Donecopride and flucopride as neuroprotective agents in the treatment of neurodegenerative diseases |
EP3952859A4 (en) * | 2019-04-12 | 2023-05-10 | Loma Linda University | METHODS OF TREATING NIEMANN-PICK TYPE C DISEASE |
CN115974839B (zh) * | 2021-12-24 | 2023-10-20 | 珠海市藤栢医药有限公司 | AChE/SERT双靶点抑制剂及其制备方法和用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2435092A (en) * | 1991-08-20 | 1993-03-16 | Smithkline Beecham Plc | 5-ht4 receptor antagonists |
PL180336B1 (pl) * | 1993-05-26 | 2001-01-31 | Syntex Inc | Nowe 1-fenyloalkanony, bedace ligandami receptorów 5-HT, kompozycja farmaceutyczna zawierajaca 1-fenyloalkanony i sposób otrzymywania 1-fenyloalkanonów PL PL PL PL PL |
CA2186623A1 (en) * | 1994-03-30 | 1995-10-21 | Takeshi Kawakita | Benzoic acid compound and use thereof as medicine |
JPH111472A (ja) * | 1996-04-30 | 1999-01-06 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体及びそれを含有する医薬組成物 |
WO1998002432A1 (en) * | 1996-07-16 | 1998-01-22 | Takeda Chemical Industries, Ltd. | Bicyclic compounds for controlling micturition |
IL150982A (en) | 2002-07-30 | 2007-02-11 | Ori Lerman | Process for making Donafzil |
US7459460B2 (en) * | 2003-05-28 | 2008-12-02 | Bristol-Myers Squibb Company | Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
GB0525661D0 (en) * | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Novel compounds |
RU2569733C2 (ru) * | 2010-02-12 | 2015-11-27 | Раквалиа Фарма Инк. | Агонисты 5-нт4-рецепторов для лечения деменции |
-
2013
- 2013-06-05 FR FR1355155A patent/FR3006686A1/fr not_active Withdrawn
-
2014
- 2014-05-19 PL PL14806879T patent/PL3004058T3/pl unknown
- 2014-05-19 WO PCT/FR2014/051149 patent/WO2014195593A2/fr active Application Filing
- 2014-05-19 HU HUE14806879A patent/HUE050953T2/hu unknown
- 2014-05-19 ES ES14806879T patent/ES2808669T3/es active Active
- 2014-05-19 EP EP14806879.4A patent/EP3004058B1/fr active Active
- 2014-05-19 US US14/895,731 patent/US9663465B2/en active Active
- 2014-05-19 PT PT148068794T patent/PT3004058T/pt unknown
- 2014-05-19 CN CN201480032241.2A patent/CN105705488B/zh active Active
- 2014-05-19 DK DK14806879.4T patent/DK3004058T3/da active
- 2014-05-19 JP JP2016517648A patent/JP6386541B2/ja active Active
-
2016
- 2016-12-01 HK HK16113674A patent/HK1225381A1/zh unknown
-
2020
- 2020-09-03 HR HRP20201402TT patent/HRP20201402T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
JP6386541B2 (ja) | 2018-09-05 |
US9663465B2 (en) | 2017-05-30 |
WO2014195593A3 (fr) | 2015-12-30 |
FR3006686A1 (fr) | 2014-12-12 |
JP2016522215A (ja) | 2016-07-28 |
DK3004058T3 (da) | 2020-08-31 |
EP3004058B1 (fr) | 2020-06-10 |
CN105705488B (zh) | 2020-03-24 |
ES2808669T3 (es) | 2021-03-01 |
US20160122300A1 (en) | 2016-05-05 |
EP3004058A2 (fr) | 2016-04-13 |
HK1225381A1 (zh) | 2017-09-08 |
PL3004058T3 (pl) | 2020-11-16 |
WO2014195593A2 (fr) | 2014-12-11 |
HRP20201402T1 (hr) | 2020-11-27 |
CN105705488A (zh) | 2016-06-22 |
PT3004058T (pt) | 2020-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285390A (en) | Arylquinazolines, their preparation and pharmaceutical preparations containing them | |
ZA201600067B (en) | Intumescent composition | |
IL241352A0 (en) | Compounds of pyruvate kinase plants, preparations containing them and their uses | |
HK1215567A1 (zh) | 五元併六元雜環化合物、其製備方法、藥物組合物和應用 | |
EP3019148A4 (en) | COMPOSITIONS WITH TWO PHENOL COMPOUNDS FOR USE IN COSMETICS | |
EP2982367A4 (en) | PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION CONTAINING DONEPEZIL | |
EP2968357A4 (en) | S-IMINO-S-OXO IMINOTHIAZINE COMPOUNDS AS INHIBITORS OF THE SITE SS CLEAVING ENZYME OF THE APP, COMPOSITIONS, AND USE THEREOF | |
PL3043778T3 (pl) | Kompozycje farmaceutyczne zawierające refametinib | |
EP2968356A4 (en) | S-IMINO-S-OXO IMINOTHIADIAZINE COMPOUNDS AS APP-SITE CLEAVING ENZYME INHIBITORS, COMPOSITIONS, AND USE THEREOF | |
EP2780341A4 (en) | CINEMA-MODULATING COMPOUNDS, COMPOSITIONS THEREFOR AND THEIR USE | |
IL241038A0 (en) | A new salt of abacinostat, a related crystalline form, a method for their preparation and pharmaceutical preparations containing them | |
DK3041476T3 (da) | Corticosteroid, der indeholder oralt disintegrerende tabletsammensætninger til eosinofil øsofagit | |
IL242437B (en) | Compound 9, 5-dimethyl-9-hydroxy-decan-4-al, its use and its preparation process | |
EP3012256A4 (en) | HETEROCYCLIC BENZIMIDAZOLE-2-PIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, PROCESS FOR PREPARATION AND USE THEREOF | |
IL244066A0 (en) | Triazolopyridine compounds, preparations and methods for their use | |
IL246406A0 (en) | History of imidazopyrazinone, their preparation and pharmaceutical preparations containing them | |
PT2988733T (pt) | Composição farmacêutica contendo macitentano cristalino | |
IL246298B (en) | History of piperidine, their preparation and pharmaceutical preparations containing them | |
HK1225381A1 (zh) | 具抗記憶錯誤效果的乙酰膽碱酯酶抑制劑和5-羥色胺受體4(5ht4)激動劑的化合物,其製備方法及其含有的藥物組合物 | |
EP3078671A4 (en) | Gemcitabine derivative, composition containing the derivative and pharmaceutical use of the derivative | |
IL239873B (en) | The history of piperidinylcarbazole, their preparation and pharmaceutical preparations containing them | |
IL239874B (en) | History of acylguanidine, their preparation and pharmaceutical preparations containing them | |
IL243012B (en) | History of hydroxy-ethylene, their preparation and pharmaceutical preparations containing them | |
GB201407847D0 (en) | Composition for the oral delivery of compounds | |
EP2930175A4 (en) | NOVEL OCTAHYDROPYRIDOQUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USES THEREFOR, AND THE DERIVATIVE THEREOF |